Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-26-213175
Filing Date
2026-05-08
Accepted
2026-05-08 06:05:18
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B2 d81251d424b2.htm 424B2 542114
2 EX-FILING FEES d81251dexfilingfees.htm   iXBRL EX-FILING FEES 41164
3 GRAPHIC g81251g01d66.jpg GRAPHIC 36978
4 GRAPHIC g81251g01g01.jpg GRAPHIC 39180
5 GRAPHIC g81251g17g17.jpg GRAPHIC 30364
  Complete submission text file 0001193125-26-213175.txt   897160

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d81251dexfilingfees_htm.xml XML 18939
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-285052 | Film No.: 26955878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)